Mechanisms for prostaglandin E2 formation caused by proteinase-activated receptor-1 activation in rat gastric mucosal epithelial cells

Biochemical Pharmacology

Volumn 73, Issue 1, 2007, Pages 103-114

  Sekiguchi, Fumiko ^a   Saito, Shino ^a   Takaoka, Kaori ^a   Hayashi, Hitomi ^a   Nagataki, Mami ^a   Nagasawa, Keita ^a   Nishikawa, Hiroyuki ^b   Matsui, Hirofumi ^c   Kawabata, Atsufumi ^a  

^a KINKI UNIVERSITY   (Japan)

^b Fuso Pharmaceutical Industries Ltd   (Japan)

^c UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Cyclooxygenase 2 (COX 2); EGF receptor trans activation; Heparin binding EGF; MAP kinases; Prostaglandin E2; Proteinase activated receptor 1 (PAR1)

Indexed keywords

CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; DISINTEGRIN; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; HEPARIN; MATRIX METALLOPROTEINASE INHIBITOR; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; PROSTAGLANDIN E2; PROTEIN KINASE C; PROTEIN TYROSINE KINASE INHIBITOR; PROTEINASE ACTIVATED RECEPTOR 1; STRESS ACTIVATED PROTEIN KINASE INHIBITOR; THROMBIN; EPIDERMAL GROWTH FACTOR; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; HEPARIN-BINDING EGF-LIKE GROWTH FACTOR; PRIMER DNA; PROSTAGLANDIN SYNTHASE INHIBITOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; EPITHELIUM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; STIMULATION; STOMACH EPITHELIUM; STOMACH MUCOSA; UPREGULATION; ANIMAL; BIOSYNTHESIS; CYTOLOGY; METABOLISM; NUCLEOTIDE SEQUENCE; PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; BASE SEQUENCE; CYCLOOXYGENASE 2; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; DNA PRIMERS; EPIDERMAL GROWTH FACTOR; EPITHELIAL CELLS; GASTRIC MUCOSA; MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; RATS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, PAR-1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 33845228293     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2006.09.016     Document Type: Article

References (45)

1. Vu T.K., Hung D.T., Wheaton V.I., and Coughlin S.R. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 64 (1991) 1057-1068
2. Nystedt S., Emilsson K., Wahlestedt C., and Sundelin J. Molecular cloning of a potential proteinase activated receptor. Proc Natl Acad Sci USA 91 (1994) 9208-9212
3. Ishihara H., Connolly A.J., Zeng D., Kahn M.L., Zheng Y.W., Timmons C., et al. Protease-activated receptor 3 is a second thrombin receptor in humans. Nature 386 (1997) 502-506
4. Kahn M.L., Zheng Y.W., Huang W., Bigornia V., Zeng D., Moff S., et al. A dual thrombin receptor system for platelet activation. Nature 394 (1998) 690-694
5. Xu W.F., Andersen H., Whitmore T.E., Presnell S.R., Yee D.P., Ching A., et al. Cloning and characterization of human protease-activated receptor 4. Proc Natl Acad Sci USA 95 (1998) 6642-6646
6. Kawabata A. PAR-2: structure, function and relevance to human diseases of the gastric mucosa. Expert Rev Mol Med 2002 (2002) 1-17
7. Ossovskaya V.S., and Bunnett N.W. Protease-activated receptors: contribution to physiology and disease. Physiol Rev 84 (2004) 579-621
8. Vergnolle N. Modulation of visceral pain and inflammation by protease-activated receptors. Br J Pharmacol 141 (2004) 1264-1274
9. Sekiguchi F., and Kawabata A. Protease-activated receptors (PARs) as therapeutic targets: development of agonists/antagonists and modulation of gastrointestinal functions. Drug Des Rev 1 (2004) 287-296
10. Kawabata A. Gastrointestinal functions of proteinase-activated receptors. Life Sci 74 (2003) 247-254
11. Kawabata A., Nishikawa H., Saitoh H., Nakaya Y., Hiramatsu K., Kubo S., et al. A protective role of protease-activated receptor 1 in rat gastric mucosa. Gastroenterology 126 (2004) 208-219
12. Kawabata A., Kinoshita M., Nishikawa H., Kuroda R., Nishida M., Araki H., et al. The protease-activated receptor-2 agonist induces gastric mucus secretion and mucosal cytoprotection. J Clin Invest 107 (2001) 1443-1450
13. Kawao N., Sakaguchi Y., Tagome A., Kuroda R., Nishida S., Irimajiri K., et al. Protease-activated receptor-2 (PAR-2) in the rat gastric mucosa: immunolocalization and facilitation of pepsin/pepsinogen secretion. Br J Pharmacol 135 (2002) 1292-1296
14. Nishikawa H., Kawai K., Nishimura S., Tanaka S., Araki H., Al-Ani B., et al. Suppression by protease-activated receptor-2 activation of gastric acid secretion in rats. Eur J Pharmacol 447 (2002) 87-90
15. Kawao N., Hiramatsu K., Inoi N., Kuroda R., Nishikawa H., Sekiguchi F., et al. The PAR-1-activating peptide facilitates pepsinogen secretion in rats. Peptides 24 (2003) 1449-1451
16. Kawabata A., Oono Y., Yonezawa D., Hiramatsu K., Inoi N., Sekiguchi F., et al. 2-Furoyl-LIGRL-NH2, a potent agonist for proteinase-activated receptor-2, as a gastric mucosal cytoprotective agent in mice. Br J Pharmacol 144 (2005) 212-219
17. Kawabata A., Nakaya Y., Ishiki T., Kubo S., Kuroda R., Sekiguchi F., et al. Receptor-activating peptides for PAR-1 and PAR-2 relax rat gastric artery via multiple mechanisms. Life Sci 75 (2004) 2689-2702
18. Dubois R.N., Abramson S.B., Crofford L., Gupta R.A., Simon L.S., Van De Putte L.B., et al. Cyclooxygenase in biology and disease. FASEB J 12 (1998) 1063-1073
19. Warner T.D., and Mitchell J.A. Cyclooxygenases: new forms, new inhibitors, and lessons from the clinic. FASEB J 18 (2004) 790-804
20. Eberhart C.E., and Dubois R.N. Eicosanoids and the gastrointestinal tract. Gastroenterology 109 (1995) 285-301
21. Kato S., Aihara E., Yoshii K., and Takeuchi K. Dual action of prostaglandin E2 on gastric acid secretion through different EP-receptor subtypes in the rat. Am J Physiol Gastrointest Liver Physiol 289 (2005) G64-G69
22. Bennett A., Stamford I.F., and Unger W.G. Prostaglandin E2 and gastric acid secretion in man. J Physiol 229 (1973) 349-360
23. Puurunen J. Effect of prostaglandin E2, cimetidine, and atropine on ethanol-induced gastric mucosal damage in the rat. Scand J Gastroenterol 15 (1980) 485-488
24. Kobayashi I., Kawano S., Tsuji S., Matsui H., Nakama A., Sawaoka H., et al. RGM1, a cell line derived from normal gastric mucosa of rat. In Vitro Cell Dev Biol Anim 32 (1996) 259-261
25. Akiba S., Hatazawa R., Ono K., Hayama M., Matsui H., and Sato T. Transforming growth factor-alpha stimulates prostaglandin generation through cytosolic phospholipase A(2) under the control of p11 in rat gastric epithelial cells. Br J Pharmacol 131 (2000) 1004-1010
26. Toyoda N., Gabazza E.C., Inoue H., Araki K., Nakashima S., Oka S., et al. Expression and cytoprotective effect of protease-activated receptor-1 in gastric epithelial cells. Scand J Gastroenterol 38 (2003) 253-259
27. Yoshisue H., and Hasegawa K. Effect of MMP/ADAM inhibitors on goblet cell hyperplasia in cultured human bronchial epithelial cells. Biosci Biotechnol Biochem 68 (2004) 2024-2031
28. Ito N., Nomura S., Iwase A., Ito T., Kikkawa F., Tsujimoto M., et al. ADAMs, a disintegrin and metalloproteinases, mediate shedding of oxytocinase. Biochem Biophys Res Commun 314 (2004) 1008-1013
29. Prenzel N., Zwick E., Daub H., Leserer M., Abraham R., Wallasch C., et al. EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature 402 (1999) 884-888
30. Kalmes A., Vesti B.R., Daum G., Abraham J.A., and Clowes A.W. Heparin blockade of thrombin-induced smooth muscle cell migration involves inhibition of epidermal growth factor (EGF) receptor transactivation by heparin-binding EGF-like growth factor. Circ Res 87 (2000) 92-98
31. Mitamura T., Higashiyama S., Taniguchi N., Klagsbrun M., and Mekada E. Diphtheria toxin binds to the epidermal growth factor (EGF)-like domain of human heparin-binding EGF-like growth factor/diphtheria toxin receptor and inhibits specifically its mitogenic activity. J Biol Chem 270 (1995) 1015-1019
32. Slice L.W., Chiu T., and Rozengurt E. Angiotensin II and epidermal growth factor induce cyclooxygenase-2 expression in intestinal epithelial cells through small GTPases using distinct signaling pathways. J Biol Chem 280 (2005) 1582-1593
33. Guo Y.S., Hellmich M.R., Wen X.D., and Townsend Jr. C.M. Activator protein-1 transcription factor mediates bombesin-stimulated cyclooxygenase-2 expression in intestinal epithelial cells. J Biol Chem 276 (2001) 22941-22947
34. Tominaga K., Higuchi K., Tsuno M., Watanabe T., Fujiwara Y., Kim S., et al. Induction of signal transduction pathways in rat gastric epithelial cells stimulated with interleukin-1beta. Aliment Pharmacol Ther 14 Suppl. 1 (2000) 101-108
35. Sasaki E., Tominaga K., Watanabe T., Fujiwara Y., Oshitani N., Matsumoto T., et al. COX-2 is essential for EGF induction of cell proliferation in gastric RGM1 cells. Dig Dis Sci 48 (2003) 2257-2262
36. Kawao N., Nagataki M., Nagasawa K., Kubo S., Cushing K., Wada T., et al. Signal transduction for proteinase-activated receptor-2-triggered prostaglandin E2 formation in human lung epithelial cells. J Pharmacol Exp Ther 315 (2005) 576-589
37. Pai R., Soreghan B., Szabo I.L., Pavelka M., Baatar D., and Tarnawski A.S. Prostaglandin E2 transactivates EGF receptor: a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy. Nat Med 8 (2002) 289-293
38. Darmoul D., Gratio V., Devaud H., Peiretti F., and Laburthe M. Activation of proteinase-activated receptor 1 promotes human colon cancer cell proliferation through epidermal growth factor receptor transactivation. Mol Cancer Res 2 (2004) 514-522
39. Lemjabbar H., and Basbaum C. Platelet-activating factor receptor and ADAM10 mediate responses to Staphylococcus aureus in epithelial cells. Nat Med 8 (2002) 41-46
40. Dong J., Opresko L.K., Dempsey P.J., Lauffenburger D.A., Coffey R.J., and Wiley H.S. Metalloprotease-mediated ligand release regulates autocrine signaling through the epidermal growth factor receptor. Proc Natl Acad Sci USA 96 (1999) 6235-6240
41. Grobelny D., Poncz L., and Galardy R.E. Inhibition of human skin fibroblast collagenase, thermolysin, and Pseudomonas aeruginosa elastase by peptide hydroxamic acids. Biochemistry 31 (1992) 7152-7154
42. Shah B.H., Baukal A.J., Shah F.B., and Catt K.J. Mechanisms of extracellularly regulated kinases 1/2 activation in adrenal glomerulosa cells by lysophosphatidic acid and epidermal growth factor. Mol Endocrinol 19 (2005) 2535-2548
43. Miyazaki Y., Hiraoka S., Tsutsui S., Kitamura S., Shinomura Y., and Matsuzawa Y. Epidermal growth factor receptor mediates stress-induced expression of its ligands in rat gastric epithelial cells. Gastroenterology 120 (2001) 108-116
44. Kato M., Nishida S., Kitasato H., Sakata N., and Kawai S. Cyclooxygenase-1 and cyclooxygenase-2 selectivity of non-steroidal anti-inflammatory drugs: investigation using human peripheral monocytes. J Pharm Pharmacol 53 (2001) 1679-1685
45. Miralpeix M., Camacho M., Lopez-Belmonte J., Canalias F., Beleta J., Palacios J.M., et al. Selective induction of cyclo-oxygenase-2 activity in the permanent human endothelial cell line HUV-EC-C: biochemical and pharmacological characterization. Br J Pharmacol 121 (1997) 171-180